COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection

University Hospital, Ioannina1 site in 1 country50 target enrollmentDecember 23, 2020

ConditionsSARS-COV2 Infection COVID-19 Disease Hospitalized Patients

Drugslow molecular weight Heparin as standard of care treatment

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: SARS-COV2 Infection
Sponsor: University Hospital, Ioannina
Enrollment: 50
Locations: 1
Primary Endpoint: EFFECT OF COVID-19 DISEASE IN CLOTTING FACTORS
Status: Completed
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Effect of Covid-19 disease in clotting factors levels in hospitalized patients

Detailed Description

Effect of Covid-19 disease in clotting factors levels in hospitalized patients positive for sars-cov2 infection. Association between clotting factors levels and disease severity,morbidity and mortality in these patients. Effect of anticoagulant therapy in the clotting factors' levels in these patients

Registry

clinicaltrials.gov

Start Date

December 23, 2020

End Date

June 23, 2021

Last Updated

4 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

University Hospital, Ioannina

Responsible Party

Principal Investigator

Liontos Angelos

CONSULTANT OF INTERNAL MEDICINE

University Hospital, Ioannina

Eligibility Criteria

Inclusion Criteria

•SINGED INFORMED CONSENT FORM
•POSITIVE PCR TEST FOR SARS-COV2 INFECTION
•FINDINGS IN CXR OR CT OF THE LUNGS CONSISTENT WITH INFECTION OF LOWER RESPIRATORY TRACT